Voluntis: Voluntis : Voluntis receives FDA 510(k) clearance for a new version of Insulia supporting an expanded range of basal insulins

(marketscreener.com) Insulia, a digital therapeutic, is now cleared by the FDA for use by people with type 2 diabetes, using a wide range of basal insulin analogues, including all approved insulin glargines Expanded range of supported insulins also integrated in CE mark received by Voluntis for Insulia 14th regulatory clearance obtained by Voluntis for a...https://www.marketscreener.com/quote/stock/VOLUNTIS-43536396/news/Voluntis-nbsp-Voluntis-receives-FDA-510-k-clearance-for-a-new-version-of-Insulia-supporting-a-35539919/?utm_medium=RSS&utm_content=20210607